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A b s t r a c t
Contrast-induced nephropathy is a serious complication after intravascular administration of iodinated contrast media and is asso-
ciated with numerous adverse outcomes. Its prevalence is particularly high in patients with multiple comorbidities who undergo coro-
nary angiography and percutaneous coronary intervention (PCI). Currently, the only effective method to prevent contrast-induced kidney 
injury is adequate hydration and a reduction of contrast volume during the intervention. Recently, new approaches aiming to minimize 
contrast usage have been proposed, i.e., ultra-low contrast angiography and zero-contrast PCI. However, neither tutorials for these 
techniques nor reviews of their outcomes exist in the literature, and therefore dissemination of these approaches among the interven-
tional community may be limited. This article presents a step-by-step description on how to perform ultra-low coronary angiography 
and zero-contrast PCI, which should help invasive cardiologists to adopt these techniques in daily practice. A review of clinical studies, 
case series and single case reports regarding these methods is also provided. Despite the promising results, such procedures still require 
some improvements and confirmation of their effectiveness as well as safety in large clinical studies. This article aims to spread these 
new techniques throughout the interventional community, which is paramount for their further development and wider utilization. 
Key words: renal insufficiency, chronic kidney disease, contrast-induced nephropathy, acute kidney injury, zero-contrast percu-
taneous coronary intervention.
S u m m a r y
Contrast-induced nephropathy (CIN) is a common complication after diagnostic and therapeutic coronary procedures 
and is independently associated with adverse outcomes. Recently, approaches aiming to minimize contrast dose during the 
interventions have been proposed which appear to be a promising preventative strategy against CIN. This article provides 
a step-by-step description on how to perform ultra-low coronary angiography and zero-contrast percutaneous coronary  
intervention, and reviews up-to-date clinical data concerning these new techniques.
Introduction
Contrast-induced nephropathy (CIN) is an acute renal 
impairment that may appear within 48–72 h after intra-
vascular administration of iodinated contrast media and 
is defined as an increase in the serum creatinine level 
of more than 0.5 mg/dl (44 μmol/l) or an increase of at 
least 25% in the level from baseline [1]. CIN particularly 
affects subjects with underlining chronic kidney disease 
(CKD), diabetes, heart failure, acute coronary syndrome 
and cardiogenic shock, and it is associated with pro-
gression of renal failure, necessity of dialysis, prolonged 
hospitalization, increased costs and mortality [1–3]. It 
has been shown that intra-arterial compared with in-
travenous contrast media administration may be linked 
to a greater risk of CIN, although the mechanism of this 
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phenomenon is not clear [4, 5]. Patients undergoing 
coronary angiography and percutaneous coronary inter-
vention (PCI) present an increased risk of CIN especially 
in the setting of urgent intervention [2, 3]. During such 
procedures, large amounts of contrast media are usually 
administered and a  strong relationship exists between 
contrast volume and a  risk of CIN [2, 3]. Adequate hy-
dration with intravenous saline infusion before and after 
intervention is a key preventative measure against CIN 
[1]. Recently, new strategies dedicated to the reduction 
of contrast volume have been proposed, and these ap-
pear to be promising approaches in the battle against 
CIN [6–12]. Such low-amount contrast procedures may 
improve patients’ outcomes, and therefore deserve dis-
semination within the interventional and wider medi-
cal communities. In this article, we present step-by-step 
principles on how to perform ultra-low contrast coronary 
angiography and zero-contrast PCI, and we review up-to-
date evidence on feasibility, safety and clinical outcomes 
of such approaches.
Catheter engagement without contrast 
administration
Both femoral and radial accesses are acceptable for 
ultra low- or zero-contrast techniques, but patients with 
advanced renal failure present a  high risk for renal re-
placement therapy, and therefore radial arteries should 
be saved for arteriovenous fistula in case of chronic he-
modialysis. In most instances, the catheter engagement 
without contrast injection does not pose a problem for 
an experienced operator. Patients with renal diseases 
usually present calcified lesions in proximal parts of their 
coronary arteries [13], and a detailed analysis of the cal-
cium distribution may help to identify the arteries and 
guide the catheter engagement. High frame rate acqui-
sition (i.e., 30 frames/s) exposes calcified changes and 
greatly facilitates identification of the vessels. To con-
firm the proper engagement, one should inject 10–20 ml 
of saline through the catheter and observe temporal 
changes in the electrocardiogram [14]. If the catheter is 
properly inserted, the saline injection induces the T-wave 
inversion or increases its amplitude along with ST-seg-
ment depression or elevation (Figure 1). One may also 
confirm the appropriate catheter position by introducing 
a coronary guidewire into the artery, i.e., if the guidewire 
follows the anatomy of the coronary artery then this is 
the confirmation of proper engagement. However, this 
method requires heparin administration and poses some 
risk of dissection when coronary lesions are not known; 
therefore, it is usually employed in the setting of PCI. 
Ultra-low contrast coronary angiography
In the ultra-low contrast technique, a  reliable coro-
nary angiography may be performed by using less than 
Figure 1. Electrocardiographic changes during an injection of 20 ml of saline into the catheter confirm proper 
engagement. A – Left coronary artery (arrow indicates T-wave increase). B – Right coronary artery (arrow indi-
cates ST-segment depression with T-wave inversion)
B








Jerzy Sacha et al. Limited contrast use for the prevention of CIN
129Advances in Interventional Cardiology 2019; 15, 2 (56)
15 ml of contrast medium [6]. A  nonionic, iso-osmolar 
contrast agent is preferred, and its pre-specified maxi-
mum volume should be based on the ratio of contrast vol-
ume (CV) per estimated glomerular filtration rate (eGFR) 
– when the ratio (i.e., CV/eGFR) is less than 1, the risk 
of CIN is significantly reduced (e.g., if the patient’s eGFR 
equals 20 ml/min/1.73 m2, the contrast volume should 
not exceed 20 ml) [15–17]. Administration of 2–3 ml 
of contrast is usually sufficient to visualize the left cor-
onary artery, but 2 ml (or even less) is enough for the 
right coronary artery. Such low-dose contrast injections 
should be performed through small diameter catheters 
(i.e., 5–6 Fr) without side-holes and with small syringes 
(e.g., 3 or 5 ml) to enable fast and easy administration 
(dye “puffing” should be avoided). 
Usually, the arterial tree appears sequentially as the 
low-contrast volume flows from its proximal to distal 
portion; therefore, the acquisition time should be appro-
priately adjusted, with a high frame rate being preferred 
(i.e., 30 frames/s) since it significantly improves vessel 
visualization. Before any drug administration (e.g., nitro-
glycerine) or when exchanging catheters, contrast medi-
um must be removed from the catheter to avoid pushing 
it into the patient. Depending on the type of catheter, 
manifold and Y connector, the volume contained in the 
whole system may range from 1.6 to more than 4 ml – 
Table I presents examples of fluid volumes filled in differ-
ent catheters and systems. After drug delivery, the cath-
eter must be refilled with 1–3 ml of contrast (depending 
of the catheter size) before cine angiography, otherwise 
the administration of a small dye volume may result in 
insufficient opacification of the artery, necessitating a re-
peated injection. 
The left coronary artery angiography usually begins 
from the spider view and then the cranial right anterior 
oblique projection is acquired; other projections depend 
on lesions’ distribution and visualization. For right cor-
onary angiography, the cranial left anterior oblique pro-
jection is usually sufficient. Optionally, acquisition with 
the right anterior oblique projection may be performed. 
If more projections are necessary, contrast dilution with 
saline 2 : 1 may limit the overall contrast amount. How-
ever, a higher dilution (e.g., 1 : 1) may yield unsatisfacto-
ry images and usually requires repeated administration. 
Another way to reduce the contrast dose is a  biplane 
angiography, which limits the number of acquisitions 
and has been proven to mitigate the risk of CIN without 
increasing radiation exposure [18]. However, many cath-
eterization laboratories are not equipped with such bi-
plane devices, and therefore this tutorial is dedicated to 
a single plane angiography, which may be easily adopted 
for a biplane version. 
Zero-contrast percutaneous coronary 
intervention
If angiographic images of coronary lesions are known, 
one may attempt to perform PCI without contrast admin-
istration. Such interventions are mainly guided by intra-
vascular ultrasound imaging (IVUS), which helps to iden-
tify the lesion and its length (i.e., “normal-to-normal” 
distance), reference vessel diameters and landing zones 
for stent implantation [6, 7]. However, the first step is 
to carefully analyze the anatomy of arteries in previous 
coronary angiography with particular consideration of 
calcified plaques. Such calcified changes may reflect the 
coronary tree without angiography and often indicate 
the position of the target lesion – a higher acquisition 
frame rate helps to expose these calcifications. The same 
projections that were employed during the angiography 
must be used for PCI, and previous angiographic imag-
es should be displayed alongside the active fluoroscopy 
screen as a  reference. Larger guide catheters are help-
ful (usually 7 Fr) since they provide better support and 
may accommodate several guidewires along with the 
IVUS probe or stents. During a meticulous insertion, the 
guidewire should exactly follow the course of the vessel 
displayed on the reference screen, and attention should 
be paid to every side branch in order to avoid acciden-
tal wiring. In general, workhorse guidewires without hy-
drophilic coated tips are preferred to mitigate the risk 
of vessel perforation. It is useful to create an excessive 
curve at the tip of the wire so that the tip will form a loop 
after crossing the stenotic lesion, and by pushing such 
a “knuckled” wire (without rotating!) one may safely in-
sert it even throughout a  tortuous vessel. Such a  loop 
usually follows the main vessel and omits side branch-
Table I. Contrast volumes contained in different diagnostic and guide catheters connected to manifold (first 
port) or standard Y connector (22 cm tube and 3-way stopcock)
Catheter Catheter alone [ml] Catheter with manifold [ml] Catheter with Y connector [ml]
Diagnostic 5 Fr 1.3 1.6 2.6 
Diagnostic 6 Fr 1.6 1.9 2.9 
Guide 6 Fr 2.6 2.9 3.9 
Guide 7 Fr 3.3 3.6 4.6 
Since blood flow elutes some contrast from the end of the catheter, the real contrast volume contained in the above systems is approximately 0.5–1.0 ml less. The 
inner diameters of the catheters were as follows: diagnostic – 0.05’’ (5 Fr); 0.57’’ (6 Fr); and guide – 0.71’’ (6 Fr); 0.081’’ (7 Fr). 
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es; moreover, it also prevents vessel perforation during 
PCI. For confirmation of proper guidewire insertion, one 
should compare the reference image taken from the pre-
vious angiography with the actual course of the wire. If 
the two images correspond, then the IVUS examination 
can be performed. When the position of guidewire is cor-
rect, but the IVUS probe cannot cross the stenotic lesion, 
its location should be recorded with cine angiography 
and such an image will provide a  reference for balloon 
pre-dilation. After pre-dilation, a  repeated IVUS exam-
ination should determine the lesion length, vessel diam-
eter and landing zones for stent implantation. The first 
non-diseased segment behind the lesion (or a segment 
with plaque burden less than 50% in cases with diffuse 
lesions) constitutes the distal landing zone, and impor-
tantly, the corresponding IVUS probe position should 
be recorded. The same has to be done for the proximal 
landing zone. It is crucial to seek landmarks that may in-
dicate the location of the landing zones. The most help-
ful landmarks are calcifications within vessels and the 
chest wall, overlying the ribs, diaphragm, surgical clips 
(in patients after coronary artery bypass grafting) as well 
as the catheter position, which all together may assist 
in proper stent positioning and implantation [7, 10, 19]. 
Figure 2 shows an example of how to take advantage of 
anatomical landmarks during zero-contrast PCI. It should 
be stressed that due to the heart motion and respira-
tion, the landing zones are usually moving in reference 
to the landmarks. Hence, one needs to carefully analyze 
the features of these movements and accordingly cov-
er such “moving landing zones” with the stent. Holding 
respiration during stent implantation should be avoided 
since a deep inspiration may significantly change the po-
sition of the entire system. After stent placement, IVUS 
imaging ascertains stent expansion and may reveal edge 
dissection. However, IVUS is not able to recognize vessel 
perforation and distal embolization. Therefore, if there is 
any doubt about the proper guidewire insertion or pres-
ence of complications, one should fill the guide catheter 
with 3 ml of contrast and then inject only 0.5–1.0 ml to 
elucidate the problem. Afterwards, the unused contrast 
must be withdrawn from the catheter (Table I). 
It should be mentioned that almost all intervention-
al techniques can be employed during zero-contrast PCI. 
Particularly, physiological assessment of coronary lesions 
with pre- and post-PCI measurements of fractional flow 
reserve (FFR) and coronary flow reserve (CFR) turned out 
to be very helpful for both procedure guidance and con-
firmation of physiological improvement after interven-
tion [7]. However, by using these techniques one needs 
to wire the vessel pre- and post-PCI, which may pose 
a risk of dissection. Yet, by holding the workhorse wire in 
the vessel and with the help of a double lumen microca-
theter, one may insert a pressure wire several times and 
do pull-back measurements with minimal risk of vessel 
damage. Also by using a single lumen microcatheter one 
may safely exchange the operating wire for a  pressure 
wire and vice versa. Another option is a rapid-exchange 
microcatheter-based pressure measurement system 
(ACIST RXi System, ACIST Medical Systems), which elimi-
nates the need for a wire exchange and provides a safer 
and more rapid assessment of FFR.
Rotational atherectomy is also feasible without con-
trast administration, since calcified plaques usually indi-
cate both the location of the culprit lesion and the extent 
of the vessel that needs to be ablated. However, this pro-
cedure can only be done in selected cases with non-com-
plex coronary anatomy [9]. One of the problems that may 
occur during rotational atherectomy is a  drop in blood 
pressure, which suggests complications, e.g., vessel rup-
ture or distal embolization. If the pressure drop persists, 
an injection of a small amount of contrast may exclude 
life-threatening complications. Other devices, such as 
embolic protection devices or thrombus aspiration cath-
eters, can also be used if the coronary artery anatomy is 
known and the vessel has been thoroughly explored with 
IVUS imaging [19, 20]. 
To adopt the technique of zero-contrast PCI in a cath-
eterization laboratory, it is reasonable to establish a local 
training program. In such a  program operators should 
train the guidewire insertion and balloon as well as stent 
positioning without contrast usage during standard PCIs 
(i.e., under ultimate control of contrast injections), and 
for maintenance of this skill, they should repeat such 
procedures periodically. In addition, they ought to imple-
ment ultra-low contrast coronary angiographies in daily 
practice.
Techniques for procedure navigation
During zero-contrast interventions, the most chal-
lenging task is proper stent positioning according to the 
landing zones determined in IVUS. The anatomical land-
marks described above (particularly calcifications within 
vessels) are crucial in the navigation of such a procedure. 
However, several other techniques have been proposed 
to provide additional assistance during the operation. 
One of these techniques is the so-called “marking wire 
technique”, where two wires are inserted into the coro-
nary artery through a double Y connector: the operating 
wire is put in via the main port but the marking wire via 
the side port of the connector (Figure 3) [11]. The marking 
wire serves as a guide for stent positioning, i.e., its tip is 
placed at the level of the distal landing zone determined 
by IVUS and then its position is secured by screwing the 
connector’s side port and by attaching a  torquer (Fig-
ures 3 A–C). With such a marking wire, one may subse-
quently determine (by using IVUS) the proximal landing 
zone and the stent length (Figure 3 D). Finally, the stent 
is positioned and implanted according to the location 
of the marking wire (Figures 3 E, F). The whole system 
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Figure 2. Zero-contrast percutaneous coronary intervention (PCI) guided by anatomical landmarks. A – Angiog-
raphy in a patient with renal dysfunction, performed 4 days before PCI, reveals 80% stenosis in middle portion 
of saphenous vein graft (SVG) to right coronary artery (RCA) (upper arrow indicates a surgical clip of other graft 
which superimposes on the ostium of SVG-RCA). B – During staged PCI, a guide catheter was engaged at the 
ostium of SVG-RCA according to the position of the overlying surgical clip – correct catheter placement was con-
firmed by inserting the guidewire into the vessel. C – Intravascular ultrasound (IVUS) identified the lesion and 
determined the proximal landing zone for stent implantation in reference to the ribs. D – The distal landing zone 
was determined at the lower edge of the rib. E – The stent was implanted in reference to the ribs. F – Due to 
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Figure 3. Marking wire technique for zero-contrast percutaneous coronary intervention (PCI). A – Right cor-
onary artery (RCA) angiography in a  patient with renal impairment performed several days prior to PCI.  
B – During staged PCI, a double Y connector was attached to the guide catheter and two guidewires were in-
serted, i.e., the operating and marking wires. C – The distal landing zone was marked with the tip of the mark-
ing wire according to the position of the intravascular ultrasound (IVUS) probe. D – The proximal landing zone 
was determined by IVUS, and the stent length was estimated with the help of a marking wire. E – The stent 
was positioned according to the marking wire. F – Due to legal issues, a single contrast injection documented 
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Figure 4. Zero-contrast percutaneous coronary intervention (PCI) with construction of a metallic silhouette 
of the vessel. A – Left coronary angiography performed several days prior to PCI shows significant stenoses 
within circumflex artery (Cx). B – The metallic silhouette of Cx is created by inserting guidewires (through a 7 Fr  
guide catheter) into the main branch and two side branches – for safety reasons, the tips of wires should be 
loop shaped. C – Intravascular ultrasound (IVUS) identifies reference diameters and landing zones for stent 





is very stable and the balloon pre-dilation or insertion 
of the IVUS probe usually does not change the marking 
wire position – although for its stability, the diameter 
of the guide catheter should not be smaller than 7 Fr. 
The marking wire technique facilitates zero-contrast PCI 
particularly in cases where the artery is tortuous or very 
mobile, and therefore the landing zones for stent implan-
tation are very hard to identify. This technique may also 
reduce the stent length, which is usually longer in PCI 
without contrast. 
Another technique that helps in orientation within 
a coronary artery relies on building a metallic silhouette 
of the vessel with guidewires [7, 8]. Side branches of-
ten provide important landmarks for stent implantation, 
and by wiring these branches along with the main vessel, 
one may create a metallic silhouette of the artery. Akin to 
the case of the main vessel, it is reasonable to wire side 
branches with loop-shaped tip guidewires. To do this, an 
excessive curve at the tip of the wire should be created, 
and after entering the side branch, one should allow the 
guidewire to form a  loop. By pushing such a guidewire 
without rotating, one can insert it to a  further portion 
of the vessel. In this way, a  silhouette of the coronary 
system is created, which constitutes a useful road map 
for the intervention (Figure 4). Moreover, such wires also 
secure side branches from occlusion during PCI.
Recently, new techniques of angiographic co-registra-
tion of imaging modalities have been utilized to navigate 
zero-contrast PCI. Real-time angiographic co-registration 
of IVUS images is very helpful in such interventions. This 
technique can be used without contrast injection and al-
lows merging of the probe position on the guidewire with 
IVUS pictures, i.e., “dry” angiographic co-registration of 
IVUS. IVUS was also combined with near-infrared spec-
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troscopy (NIRS) to determine plaque composition during 
zero-contrast PCI of saphenous vein grafts, which proved 
to be useful in deciding whether to use a embolic pro-
tection device [20]. In several reports, optical coherence 
tomography (OCT) with angiographic co-registration was 
employed to guide the procedure [8, 21, 22]. Since the 
contrast medium could not be used for blood flushing 
during OCT, it was replaced by a mixture of saline and 
colloid or dextran-40 – these solutions provided suffi-
cient image quality in OCT and had a good safety profile. 
After PCI, repeated co-registered OCT determined the 
minimal stent area and guided post-dilation. These cases 
highlight the feasibility of radio-contrast free OCT as an 
imaging option for guiding zero-contrast PCI [8, 21, 22]. 
Safety measures
As in any other invasive coronary procedures, it is 
mandatory to monitor hemodynamics throughout the 
interventions. Even though zero-contrast PCI seems to be 
safe in experienced hands, it may, however, be associat-
ed with serious complications. Therefore, it is advisable 
to perform such procedures only for large and prognos-
tically or clinically relevant coronary vessels. The risk of 
complications is probably higher when the target vessel 
diameter is small. In such circumstances, incorrect wir-
ing of small side branches is very likely, and if unrecog-
nized, may lead to perforation. Indeed, procedures with-
out contrast may potentially miss coronary perforation; 
hence baseline and post-PCI echocardiography should 
be performed to check for pre-existing pericardial effu-
sion and new or enlarging effusion after PCI. Due to le-
gal issues, it is sensible to document the final PCI result 
with a  single injection of a  small contrast volume. The 
amount of 2–3 ml of contrast should not pose a problem 
for renal function, but may reveal initial signs of compli-
cations, e.g., perforation and distal embolization – such 
an approach allows early bail-out management. Some 
other situations may require radio-contrast angiography 
during zero-contrast PCI, i.e., persistent chest pain, new 
electrocardiographic changes, hemodynamic compro-
mise, lack of improvement in physiological indices (i.e., 
FFR, CFR) and new or enlarging pericardial effusion [7]. 
Even in such conditions, contrast volume should be as 
low as possible, but it still must be sufficient to manage 
complications effectively. Therefore, before making the 
decision of performing zero-contrast PCI, its potential 
benefit, anatomical conditions and patient’s preferences 
must be considered.
Adequate patient’s hydration  
in zero-contrast interventions
Although contrast volume reduction plays a  critical 
role in preventing CIN, adequate patient’s hydration 
remains the cornerstone for this prevention. In the 
POSEIDON trial, left ventricular end-diastolic pressure 
(LVEDP) guided fluid administration proved to be very 
effective and a safe way to prevent CIN in patients un-
dergoing cardiac catheterization [23]. According to this 
study, each patient should receive a bolus of saline infu-
sion at 3 ml/kg for 1 h before the procedure. In the set-
ting of the catheterization laboratory, a pigtail catheter 
should be placed into the left ventricle for the baseline 
LVEDP measurement. Then, the fluid rate administra-
tion is adjusted in line with LVEDP, i.e.: 5 ml/kg/h for 
LVEDP lower than 13 mm Hg, 3 ml/kg/h for LVEDP of 
13–18 mm Hg, and 1.5 ml/kg/h for LVEDP higher than 
18 mm Hg. Such a fluid rate is started at the beginning 
of the procedure and continued during the procedure 
and for the next 4 h. If the patient’s body mass is higher 
than 100 kg, the bolus and infusion rate should be lim-
ited to those calculated for subjects weighing 100 kg. 
Such a management in the POSEIDON trial significantly 
reduced the incidence of CIN compared with the standard 
protocol (i.e., 6.7% vs. 16.3%) [23], and may constitute an 
excellent supplementary treatment in zero-contrast PCI.
Current clinical evidence
Ultra-low contrast coronary angiography and zero- 
contrast PCI are new approaches in the prevention of 
CIN; therefore, clinical data regarding their feasibility, ef-
ficacy and safety are limited. The first description of the 
method with presentation of 4 cases was published by 
Nayak et al. in 2010. PCIs were performed ad hoc with no 
complications and none of the patients developed CIN 
[6]. However, the first substantial evidence of the feasi-
bility and efficacy of zero-contrast PCI in the prevention 
of CIN was provided by Ali et al., who performed diagnos-
tic angiography using ultra-low contrast volume followed 
by staged zero-contrast PCI in 31 patients with advanced 
CKD (mean eGFR: 16 ml/min/1.73 m2) [7]. The median 
contrast volume during angiography was 13 ml (median 
CV/eGFR ratio: 0.8) and a week later patients underwent 
PCI guided only by IVUS imaging and measurements of 
physiological indices (i.e., FFR and CFR). The median in-
tervention time was 72 min, median radiation dose was 
1154 mGy, no procedural complications occurred, and no 
patient developed CIN. The same group published a series 
of 3 patients who underwent zero-contrast PCI facilitat-
ed with rotational atherectomy [9]. This report highlights 
the feasibility of performing rotational atherectomy as 
a part of zero-contrast PCI in selected patients with se-
vere coronary calcifications. 
There are several single case reports documenting PCI 
with no contrast for different anatomical settings, includ-
ing complex left main stenosis, saphenous vein graft ob-
struction, multivessel disease and chronic total occlusion 
[10, 12, 19, 20, 24]. All of these cases were performed 
as staged procedures, none of these subjects developed 
CIN and no complications were reported. However, pub-
lication bias is likely since operators usually do not re-
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port failed or complicated cases. In several reports, OCT 
without contrast was used as a primary imaging modal-
ity; nevertheless, the majority of zero-contrast PCIs were 
guided by IVUS. Due to its simplicity and wide availabil-
ity, IVUS imaging appears to be the preferred method. 
Strong evidence that IVUS-guided PCI is safe and sig-
nificantly reduces contrast dose was provided by the 
MOZART trial where 83 patients were randomly assigned 
to angiography-guided PCI or IVUS-guided PCI [25]. The 
IVUS approach was associated with a 3-fold reduction in 
contrast dose compared with the angiography arm (me-
dian volumes: 20.0 ml vs. 64.5 ml, respectively) and it 
was not related to any specific complications. However, 
the study was not powered to detect differences in hard 
endpoints, and most of the subjects presented relatively 
good renal function; hence, no clinical benefit (including 
reduction of CIN) was observed [24]. 
Recently, one prospective study and another retro-
spective analysis showed that ultra-low contrast tech-
niques guided by only angiography (without IVUS and 
OCT) is feasible and can safely be used in patients with 
CKD [26, 27]. These single arm studies showed that 
contrast dose might be reduced to a  median volume 
of 13 to 15.2 ml for diagnostic angiography and 13 to 
17.1 ml for PCI, which was associated with a  low rate 
of CIN [26, 27]. Although this approach is cheaper 
compared with IVUS- or OCT-guided procedures, there 
are some concerns about its long-term outcomes, i.e., 
whether ultra-low contrast PCI without intravascular 
imaging ensures optimal results. Therefore, studies with 
long-term follow-up are needed to check clinical out-
comes of this approach. 
It should also be established whether staged proce-
dures, after minimal contrast diagnostic angiography, 
present any benefit over ad hoc PCI. Deferral of the in-
tervention facilitates procedural planning and enables us 
to discuss all treatment options with patients as well as 
obtain their informed consent [7]. In a study by Ali et al., 
staged PCI was performed no earlier than 7 days after 
angiography, i.e., when the contrast agent is expected 
to be completely excreted by the kidneys; the authors 
argue that their excellent results with no CIN incidents 
prove the appropriateness of such an approach [7, 28]. 
Deferred PCI permits optimal patient hydration, which is 
a critical element in CIN prevention, including zero-con-
trast interventions [1, 23]. However, in our recent study, 
13 patients with acute coronary syndrome underwent 
zero-contrast PCI and 4 of them suffering from non-ST-
segment elevation myocardial infarction were treated 
with ad hoc procedures with very good clinical outcomes 
[29]. Thus, regardless of the mode of intervention (ad hoc 
or staged), subjects with severe renal impairment seem 
to benefit from zero-contrast PCI. Yet, due to the need 
of adequate hydration, a staged approach should rather 
be standard in most cases except those with acute coro-
nary syndromes where the clinical context must be taken 
into account when making a decision about the time of 
intervention. 
A new concept for the use of the zero-contrast ap-
proach is the protection of residual renal function in he-
modialysis patients undergoing coronary interventions 
[12 , 29]. It has been demonstrated that the residual re-
nal function is a prognostic and independent factor of 
quality of life, morbidity and survival in dialysis patients, 
and therefore every protective measure to preserve this 
function is worth considering [30]. In our recent study, 
4 dialysis subjects were treated with zero-contrast PCI 
and 3 of them preserved their remaining renal function 
[29]. However, despite this promising observation, the 
concept should be addressed in appropriate prospective 
studies before it is recommended for wide clinical prac-
tice.
Conclusions
Contrast-induced nephropathy is a  common com-
plication after diagnostic and therapeutic coronary pro-
cedures and is independently associated with adverse 
outcomes. Although many therapies have been tested to 
avoid CIN, the only potent preventative strategy involves 
aggressive fluid administration and reduction of contrast 
volume. Approaches aiming to minimize contrast dose 
have become new and effective weapons in the battle 
with CIN. However, despite the first promising results, 
they still require further development and confirmation 
of their effectiveness as well as safety in large clinical 
studies. Advances in imaging techniques will certainly fa-
cilitate such interventions and should cause a growth of 
interest in these approaches. However, to adopt contrast 
limiting techniques, invasive cardiologists must change 
their routines in daily practice. First, during both angiog-
raphy and PCI, they ought to seek anatomical landmarks 
(particularly calcifications) to navigate their interventions 
without contrast usage. Second, small injections with 
small syringes as well as evacuation of unused contrast 
from catheters must be standard. Finally, wider use of in-
travascular imaging techniques (especially IVUS) should 
decrease contrast volume and improve PCI results. This 
article summarizes the principles of these approaches 
and should help in spreading them among the interven-
tional community. 
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